What is the 1st line of treatment for colorectal cancer

According to the NCCN (National Comprehensive Cancer Network) Guidelines for Colorectal Cancer (2023), the first-line treatment depends primarily on the stage of cancer at diagnosis:

For Early-Stage Colorectal Cancer (Stage I-III):

• Surgery is typically the primary first-line treatment
• For stage III and some high-risk stage II patients, adjuvant chemotherapy follows surgery

For Stage IV (Metastatic) Colorectal Cancer: The American Society of Clinical Oncology (ASCO) Guidelines recommend:

1. Molecular testing of the tumor for:

• RAS mutations (KRAS/NRAS)
• BRAF mutations
• MSI (microsatellite instability) status

Based on these results, first-line treatment typically includes:

• For RAS wild-type tumors: Chemotherapy (FOLFOX or FOLFIRI) plus targeted therapy (like cetuximab or bevacizumab)
• For RAS-mutated tumors: Chemotherapy plus bevacizumab

The National Cancer Institute (NCI) emphasizes that treatment plans should be individualized based on:

• Cancer stage
• Location of the tumor
• Genetic markers
• Patient's overall health
• Patient preferences

Always consult with your oncology team for specific treatment recommendations, as they will consider your individual case characteristics and preferences.